Pharmaceuticals UAE

UAE Chronic Urticaria Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

UAE Chronic Urticaria Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UAE · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $19.2 Mn Placeholder estimate
Estimate 2025 $20.9 Mn 0.5% of the global market
Projected 2034 $45.4 Mn 117.2% Adds $24.5 Mn over 9 forecast years
CAGR 2025–2034 9.0% Faster than 49% of 180 Pharmaceuticals markets here
Key players 5
  • UAE is 0.51% of the global market.
  • In Middle East, the largest is Saudi Arabia at $65.6 Mn.
  • Fastest growing: Saudi Arabia at 9.5% a year.
  • UAE ranks 2nd of 2 by size in Middle East.

Market size projection

UAE

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$24.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Chronic Urticaria Treatment Market market size by year, UAE
YearMarket sizeChange that yearSince 2025
2024 (estimate) $19.2 Mn — —
2025 (base) $20.9 Mn +$1.7 Mn —
2026 (forecast) $22.8 Mn +$1.9 Mn +9%
2027 (forecast) $24.8 Mn +$2.1 Mn +18.8%
2028 (forecast) $27.1 Mn +$2.2 Mn +29.5%
2029 (forecast) $29.5 Mn +$2.4 Mn +41.2%
2030 (forecast) $32.2 Mn +$2.7 Mn +53.9%
2031 (forecast) $35.1 Mn +$2.9 Mn +67.7%
2032 (forecast) $38.2 Mn +$3.2 Mn +82.8%
2033 (forecast) $41.7 Mn +$3.4 Mn +99.3%
2034 (forecast) $45.4 Mn +$3.7 Mn +117.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $4.08 Bn
  2. North America $1.76 Bn
  3. US $1.41 Bn
  4. Europe $741.7 Mn
  5. APAC $771.5 Mn
  6. China $351.9 Mn
  7. Canada $279.8 Mn
  8. Japan $254.2 Mn
  9. Latin America $168.8 Mn
  10. Germany $149.1 Mn
  11. Middle East $153.3 Mn
  12. Brazil $119.4 Mn
  13. France $113.6 Mn
  14. UK $92.3 Mn
  15. Italy $93.3 Mn
  16. India $82.8 Mn
  17. Spain $74.5 Mn
  18. Ecuador $71.9 Mn
  19. Saudi Arabia $65.6 Mn
  20. Africa $63.8 Mn
  21. Mexico $61.5 Mn
  22. Australia $46.4 Mn
  23. New Zealand $41.4 Mn
  24. Russia $40.6 Mn
  25. South Africa $28.1 Mn
  26. UAE (this report) $20.9 Mn
  27. Egypt $11.0 Mn
  28. Philippines $8.0 Mn
  29. Hong Kong $6.6 Mn
  30. Malaysia $6.1 Mn
  31. Thailand $5.0 Mn
  32. Singapore $4.7 Mn
  33. Kenya $2.6 Mn

Report snapshot

UAE Chronic Urticaria Treatment Market Analysis at a glance
Market size, 2025$20.9 Mn placeholder estimate
Forecast, 2034$45.4 Mn placeholder estimate
Growth (CAGR), 2025–20349.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDrug class, type and end user (see all)
Key playersNovartis AG, Sanofi, Regeneron Pharmaceuticals, Celldex Therapeutics, Roche (see all)
Regulator in the UAEEDESource: Emirates Drug Establishment. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UAE Chronic Urticaria Treatment Market Analysis Executive Summary

Chronic urticaria treatments control long-lasting hives and itching that do not go away with standard antihistamines.

Key segments of the chronic Urticaria Treatment market include drug class (Antihistamines, Anti-IgE Biologics and BTK Inhibitors) and type (Chronic Spontaneous Urticaria and Chronic Inducible Urticaria).

Bar chart: UAE Chronic Urticaria Treatment market size, 2024–2034, placeholder estimates. $19.2 Mn in 2024, $20.9 Mn in 2025 and $45.4 Mn in 2034, 9.0% CAGR.
UAE Chronic Urticaria Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UAE Chronic Urticaria Treatment Market Dynamics

Market Growth Drivers

More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the chronic Urticaria Treatment market. Biosimilars are widening access.

Opportunity

New targets, oral drugs that replace injections and cell therapies for autoimmune disease give the chronic Urticaria Treatment market room to grow.

Market Restraints

High prices, infection risks with immune-suppressing drugs, patent expiries and the need for long-term treatment hold back the chronic Urticaria Treatment market.

Competitive Landscape for Chronic Urticaria Treatment Market in UAE

The chronic Urticaria Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Chronic Urticaria Treatment Market in UAE

Chronic Urticaria Treatment in the UAE: rules and payment

The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medicines from the Ministry of Health and Prevention.⁠[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.⁠[2]

[1] Emirates Drug Establishment. Checked 14 Nov 2026.

[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for chronic Urticaria Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in UAE.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Chronic Urticaria Treatment right now, from free public sources.

Latest research 677 papers since 2021 (worldwide)

  1. From the skin to the thyroid: immunological mechanisms and therapeutic implications of the comorbidity between chronic spontaneous urticaria and autoimmune thyroid disease. Frontiers in immunology, 2026
  2. Key Players and Pathways of Mast Cell Activation in Urticaria. Journal of inflammation research, 2026
  3. MRGPRX2 in Allergic and Immune-Mediated Diseases: Mechanisms, Clinical Relevance, and Therapeutic Translation. Clinical reviews in allergy & immunology, 2026
  4. The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach. Italian journal of dermatology and venereology, 2026
  5. Treatment-refractory chronic urticaria with neutrophilia and elevated inflammatory markers. Allergy and asthma proceedings, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Chronic Urticaria Treatment in context

The UAE compared

  • Health spending per person: 2,402 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 2.99 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 3rd highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 1.8% of people (2025). World: 10.4% of people (2025). 8th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Chronic Urticaria Treatment market in the UAE?
Placeholder estimate: about $20.9 Mn in 2025, rising to about $45.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Chronic Urticaria Treatment market in the UAE growing?
Placeholder estimate: about 9.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Chronic Urticaria Treatment market report cover?
The report splits the market by drug class (Antihistamines, Anti-IgE Biologics, BTK Inhibitors, Others), type (Chronic Spontaneous Urticaria, Chronic Inducible Urticaria) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Chronic Urticaria Treatment market?
Key players include Novartis AG, Sanofi, Regeneron Pharmaceuticals, Celldex Therapeutics and Roche.
What is driving the Chronic Urticaria Treatment market?
More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the chronic Urticaria Treatment market. Biosimilars are widening access.
Who regulates Chronic Urticaria Treatment in the UAE?
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medicines from the Ministry of Health and Prevention. Source: Emirates Drug Establishment. Checked 14 Nov 2026.
How is healthcare paid for in the UAE?
Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate. Source: Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
How much research is published on Chronic Urticaria Treatment?
PubMed lists 677 papers on Chronic Urticaria Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Chronic Urticaria Treatment in UAE? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Collagen Supplements: Skin, Joints and Real EvidenceCollagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Aesthetic Lasers: The Boom in Non-Surgical BeautyPlastic surgeons performed more than 19.1 million non-surgical aesthetic procedures in 2023. Hair removal and…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in UAE

See all
Same topic, other categories

Related on allergies and skin and hair

See the topic